fludarabine has been researched along with Central Nervous System Toxoplasmosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desmond, R; Farrell, M; Gleeson, M; Lynch, K; Murphy, P | 1 |
| Bacchu, S; Fegan, C; Neal, J | 1 |
| Fezoui, H; Genet, P; Lionnet, F; Louvel, D; Pulik, M; Touahri, T | 1 |
3 other study(ies) available for fludarabine and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Humans; Immunocompromised Host; JC Virus; Leukemia, Lymphocytic, Chronic, B-Cell; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; Rituximab; Toxoplasmosis, Cerebral; Vidarabine; Virus Activation | 2010 |
Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Topics: Aged, 80 and over; Antineoplastic Agents; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Opportunistic Infections; Toxoplasmosis, Cerebral; Vidarabine | 2007 |
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Interferon-alpha; Lymphoma, Follicular; Opportunistic Infections; Prednisone; Salvage Therapy; Teniposide; Toxoplasmosis, Cerebral; Vidarabine | 2002 |